Author

Lydia Murdiyarso

The University of Melbourne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:clustering· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

Adam K. WheatleyiD· 3 shared Hyon‐Xhi TaniD· 2 shared Jennifer A. JunoiD· 2 shared Robyn EsterbaueriD· 2 shared Stephen John KentiD· 2 shared A Kelly· 1 shared Allen C Cheng· 1 shared Andrew P. KellyiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Adam K. WheatleyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Defining influenza-specific B cells in vaccine responders, non-responders and influenza breakthrough infections

Łukasz Kedzierski, Ashleigh I. Holloway, Jennifer R. Habel, Louise C. Rowntree, Shihan Li, Hayley A. McQuilten, Fiona James, Lydia Murdiyarso, Ilariya Tarasova, Nancy Leung, Yuyun Chen, Dkm Ip, Stephen John Kent, Malik J. S. Peiris, Steven Y C Tong, , Katherine Kedzierska

This study identifies atypical B cell markers associated with influenza vaccine non-responsiveness and severe infection using single-cell transcriptomics.

bioRxiv · Mar 22, 2026 · PreprintImmunology

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses

Veronica P. Zoest, Wen Shi Lee, Lydia Murdiyarso, Lauren Burmas, Phillip Pymm, Robyn Esterbauer, Andrew P. Kelly, Hannah G. Kelly, Isaac Michael Barber-Axthelm, James P. Cooney, Kathryn C. Davidson, Merle Dayton, Courtney E. McAleese, Marianne Gillard, Karen Hughes, , Hyon‐Xhi Tan

A chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and HKU-1 scaffold domains elicits potent neutralising antibodies and CD4 T cell help in mice and macaques.

npj Vaccines · Nov 28, 2025Peer-reviewedImmunology

Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality

Hyon‐Xhi Tan, MZM Zheng, Kathleen M. Wragg, Lydia Murdiyarso, Devaki Pilapitiya, A Kelly, Robyn Esterbauer, Christopher A. Gonelli, Adam K. Wheatley, Jennifer A. Juno

The paper investigates the relationship between CD4 T cell epitope immunodominance and vaccine-induced T follicular helper cell quality, finding that immunodominance is not predictive of helper quality.

bioRxiv · Jul 21, 2025 · PreprintImmunology